Higher BMI tied to immune checkpoint inhibitor-induced thyroid dysfunction
Treatment with PD-1/L1 inhibitors is associated with the development of thyroid immune-related adverse events (irAEs), particularly overt thyrotoxicosis, with increasing body mass index (BMI), a recent study has found.
